Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 1Dermatologic 1CNS 1

Conditions

Oligodendroglioma 2Central Nervous System Neoplasms 2Astrocytoma 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Optic Nerve Glioma 1Meningioma 1Medulloblastoma 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Familial ependymoma 1Esthesioneuroblastoma, Olfactory 1Choroid Plexus Neoplasms 1Carcinoma, Medullary 1Brain Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

Docetaxel 7Radiotherapy 6Filgrastim 6Cisplatin 4Peripheral Blood Stem Cell Transplantation 3Chemotherapy, Adjuvant 3Carboplatin 3selpercatinib 2sargramostim 2Thiotepa 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Nivolumab 2Gemcitabine 2Etoposide 2Drug Therapy 2Doxorubicin 2Capecitabine 2Biopsy 2Acupuncture Therapy 2vocimagene amiretrorepvec 1vandetanib 1ulixertinib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1spartalizumab 1pentetreotide 1pazopanib 1oncogene protein E7, Human papillomavirus type 16 1oblimersen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Semaxinib × CNS × Clear all
NCT00005647 2010-06-10

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Case Comprehensive Cancer Center

Phase 1 Completed
12 enrolled
CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡